临床推理：一位 77 岁男性，出现不自主运动、睡眠改变、跌倒、球部症状和认知主诉。
Clinical Reasoning: A 77-Year-Old Man With Involuntary Movements, Sleep Changes, Falls, Bulbar Symptoms, and Cognitive Complaints.
机构信息
From the Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL.
出版信息
Neurology. 2022 Jul 4;99(1):26-30. doi: 10.1212/WNL.0000000000200705.
Abstract
A 77-year-old-man presents with chorea, parasomnias, dysarthria and dysphagia, and cognitive issues. A broad workup reveals positive anti-IgLON5 antibody. This case report represents a textbook example of anti-IgLON5 syndrome.
摘要
一位 77 岁男性出现舞蹈症、睡眠障碍、构音障碍和吞咽困难，以及认知问题。广泛的检查显示抗 IgLON5 抗体阳性。本病例报告代表了抗 IgLON5 综合征的典型范例。
相似文献
1
Clinical Reasoning: A 77-Year-Old Man With Involuntary Movements, Sleep Changes, Falls, Bulbar Symptoms, and Cognitive Complaints.临床推理：一位 77 岁男性，出现不自主运动、睡眠改变、跌倒、球部症状和认知主诉。
Neurology. 2022 Jul 4;99(1):26-30. doi: 10.1212/WNL.0000000000200705.
2
Differentiating anti-IgLON5 disease and Lewy body dementia: a systematic review.鉴别抗 IgLON5 病与路易体痴呆：系统评价。
J Neurol. 2024 Apr;271(4):1707-1716. doi: 10.1007/s00415-023-12145-8. Epub 2024 Jan 9.
3
A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem study.一种新型非快速眼动和快速眼动睡眠障碍相关呼吸暂停与 IgLON5 抗体相关：病例系列、抗原特征和尸检研究。
Lancet Neurol. 2014 Jun;13(6):575-86. doi: 10.1016/S1474-4422(14)70051-1. Epub 2014 Apr 3.
4
Behavioral and psychological treatments for NREM parasomnias: A systematic review.非快速眼动期睡眠行为障碍的行为和心理治疗：系统评价。
Sleep Med. 2023 Nov;111:36-53. doi: 10.1016/j.sleep.2023.09.004. Epub 2023 Sep 6.
5
Clinical manifestations of the anti-IgLON5 disease.抗IgLON5疾病的临床表现。
Neurology. 2017 May 2;88(18):1736-1743. doi: 10.1212/WNL.0000000000003887. Epub 2017 Apr 5.
6
Hypothalamic-Bulbar MRI Hyperintensity in Anti-IgLON5 Disease with Serum-Restricted Antibodies: A Case Report and Systematic Review of Literature.抗 IgLON5 病伴血清限制抗体的下丘脑-延髓 MRI 高信号：病例报告及文献系统回顾。
J Alzheimers Dis. 2021;79(2):683-691. doi: 10.3233/JAD-201105.
7
Patient With Rigidity and Fasciculations: Steroid-Responsive Presentation of Anti-IgLON5 Disease.僵直和肌束颤动的患者：抗 IgLON5 病的类固醇反应性表现。
Neurology. 2024 Feb 13;102(3):e208110. doi: 10.1212/WNL.0000000000208110. Epub 2024 Jan 11.
8
Improvement in mild anti-IgLON5 encephalopathy without immunotherapy: a case report.免疫治疗不改善轻中度抗 IgLON5 相关疾病：病例报告。
BMC Neurol. 2021 Mar 17;21(1):120. doi: 10.1186/s12883-021-02145-4.
9
Psychopathology and NREM sleep parasomnias: A systematic review.精神病理学与非快速眼动睡眠异态睡眠：一项系统综述。
Sleep Med Rev. 2025 Apr;80:102043. doi: 10.1016/j.smrv.2024.102043. Epub 2024 Dec 15.
10
Anti-IgLON5 disease complicated with rectal adenocarcinoma: a case report.抗 IgLON5 病并发直肠腺癌：病例报告。
BMC Neurol. 2023 Jan 3;23(1):1. doi: 10.1186/s12883-022-03044-y.
引用本文的文献
1
Anti-IgLON5 Disease with Isolated Hemichorea: A Case Report and Review of the Literature.伴孤立性偏侧舞蹈症的抗IgLON5病：一例报告及文献复习
Mov Disord Clin Pract. 2022 Nov 24;10(1):115-119. doi: 10.1002/mdc3.13614. eCollection 2023 Jan.
本文引用的文献
1
Frequency and Characterization of Movement Disorders in Anti-IgLON5 Disease.抗IgLON5疾病中运动障碍的频率及特征
Neurology. 2021 Oct 4;97(14):e1367-e1381. doi: 10.1212/WNL.0000000000012639.
2
Response to immunotherapy in anti-IgLON5 disease: A systematic review.抗 IgLON5 病免疫治疗反应：系统评价。
Acta Neurol Scand. 2020 Apr;141(4):263-270. doi: 10.1111/ane.13207. Epub 2020 Jan 12.
3
Anti-IGLON5 disease: A new case without neuropathologic evidence of brainstem tauopathy.抗 IGLON5 病：一例无脑干 tau 病神经病理学证据的新病例。
Neurol Neuroimmunol Neuroinflamm. 2019 Dec 11;7(2). doi: 10.1212/NXI.0000000000000651. Print 2020 Mar.
4
Immunotherapy improves sleep and cognitive impairment in anti-IgLON5 encephalopathy.免疫疗法可改善抗IgLON5脑病患者的睡眠和认知障碍。
Neurol Neuroimmunol Neuroinflamm. 2019 May 21;6(4):e577. doi: 10.1212/NXI.0000000000000577. eCollection 2019 Jul.
5
Neurological profiles beyond the sleep disorder in patients with anti-IgLON5 disease.抗 IgLON5 病患者除睡眠障碍外的神经学特征。
Curr Opin Neurol. 2019 Jun;32(3):493-499. doi: 10.1097/WCO.0000000000000677.
6
IgLON5 antibody: Neurological accompaniments and outcomes in 20 patients.IgLON5抗体：20例患者的神经学伴随症状及转归
Neurol Neuroimmunol Neuroinflamm. 2017 Jul 18;4(5):e385. doi: 10.1212/NXI.0000000000000385. eCollection 2017 Sep.
7
Cell surface antibody-associated neurodegeneration: The case of anti-IgLON5 antibodies.细胞表面抗体相关的神经退行性变：抗 IgLON5 抗体的病例
Neurology. 2017 May 2;88(18):1688-1690. doi: 10.1212/WNL.0000000000003931. Epub 2017 Apr 5.
8
Clinical manifestations of the anti-IgLON5 disease.抗IgLON5疾病的临床表现。
Neurology. 2017 May 2;88(18):1736-1743. doi: 10.1212/WNL.0000000000003887. Epub 2017 Apr 5.
9
Neuropathological criteria of anti-IgLON5-related tauopathy.抗IgLON5相关tau蛋白病的神经病理学标准。
Acta Neuropathol. 2016 Oct;132(4):531-43. doi: 10.1007/s00401-016-1591-8. Epub 2016 Jun 29.
10
MDS clinical diagnostic criteria for Parkinson's disease.帕金森病的MDS临床诊断标准。
Mov Disord. 2015 Oct;30(12):1591-601. doi: 10.1002/mds.26424.
Zotero 插件